Commentary: De Novo Self-Mutilation and Depressive Symptoms in a 17-year-old Adolescent Girl Receiving Depot-Medroxyprogesterone Acetate.
Department of Mental Health and Substance Abuse Services, National Institute for Health and Welfare (THL), Helsinki, Finland.
Elena
E
Toffol
Oskari
O
Heikinheimo
Timo
T
Partonen